All In Biotech

Free tool

FAERS Monitor: Ritalin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 010187 or its brand name (Ritalin, Methylphenidate Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

24,249

Serious

14,895

61% of reports

Hospitalization

5,209

Death reported

1,137

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,492
  • fatigue1,726
  • nausea1,471
  • headache1,395
  • anxiety1,352
  • depression1,172
  • somnolence989
  • off label use951
  • insomnia937
  • feeling abnormal904
  • dizziness852
  • weight decreased795
  • vomiting765
  • pain761
  • suicidal ideation716

Reports by year received

View as table
YearReports
2004400
2005420
2006407
2007386
2008401
2009443
2010512
2011572
2012699
2013647
2014797
20151,779
20163,218
20171,771
20181,815
20191,649
20201,277
2021961
20221,203
20231,385
20241,288
20251,263
2026955

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,910 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
suicidal ideationSignal7166.86.43,545
depressionSignal1,1724.54.23,189
somnolenceSignal9894.34.02,491
anxietySignal1,3524.13.93,240
feeling abnormalSignal9043.33.11,442
insomniaSignal9373.12.91,308
weight decreasedSignal7952.52.3704
headache1,3951.91.8644
fatigue1,7261.91.8794
drug ineffective2,4921.61.6664
nausea1,4711.61.5355
dizziness8521.51.4136
vomiting7651.41.393
pain7611.11.04
off label use9510.90.93

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.